Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program

AIMS: Sodium glucose co‐transporter 2 (SGLT2) inhibitors reduce several cardiovascular risk factors, including plasma glucose, blood pressure, albuminuria and body weight. Long‐term treatment lowers risks of cardiovascular and renal events. The objective of this post hoc analysis was to determine th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Ohkuma, Toshiaki, Van Gaal, Luc, Shaw, Wayne, Mahaffey, Kenneth W., de Zeeuw, Dick, Matthews, David R., Perkovic, Vlado, Neal, Bruce
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078821/
https://ncbi.nlm.nih.gov/pubmed/31729107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13920
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados